These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1078 related articles for article (PubMed ID: 30203487)
1. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT. Yuan Q; Zhang Y; Feng L; Jiang Y J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT. Xu H; Zheng JF; Hou CZ; Li Y; Liu PS Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022 [TBL] [Abstract][Full Text] [Related]
3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
4. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b. Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592 [TBL] [Abstract][Full Text] [Related]
5. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081 [TBL] [Abstract][Full Text] [Related]
6. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma. Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528 [TBL] [Abstract][Full Text] [Related]
7. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Li Z; Jiang P; Li J; Peng M; Zhao X; Zhang X; Chen K; Zhang Y; Liu H; Gan L; Bi H; Zhen P; Zhu J; Li X Oncogene; 2018 Jul; 37(28):3822-3838. PubMed ID: 29643475 [TBL] [Abstract][Full Text] [Related]
8. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028 [TBL] [Abstract][Full Text] [Related]
9. High Expression of Long Noncoding RNA HOTAIRM1 is Associated with the Proliferation and Migration in Pancreatic Ductal Adenocarcinoma. Luo Y; He Y; Ye X; Song J; Wang Q; Li Y; Xie X Pathol Oncol Res; 2019 Oct; 25(4):1567-1577. PubMed ID: 30613920 [TBL] [Abstract][Full Text] [Related]
10. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis. Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494 [TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis. Zhang Y; Ma H; Chen C Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036383 [TBL] [Abstract][Full Text] [Related]
12. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma. Lu Y; Wu M; Fu J; Sun Y; Furukawa K; Ling J; Qin X; Chiao PJ Cell Prolif; 2020 May; 53(5):e12805. PubMed ID: 32364285 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2. Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517 [TBL] [Abstract][Full Text] [Related]
14. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763 [TBL] [Abstract][Full Text] [Related]
15. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma. Meng F; Li W; Li C; Gao Z; Guo K; Song S Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147 [TBL] [Abstract][Full Text] [Related]
16. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma. Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways. Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034 [TBL] [Abstract][Full Text] [Related]
19. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270 [TBL] [Abstract][Full Text] [Related]
20. Tumor-derived exosomal long noncoding RNA LINC01133, regulated by Periostin, contributes to pancreatic ductal adenocarcinoma epithelial-mesenchymal transition through the Wnt/β-catenin pathway by silencing AXIN2. Liu Y; Tang T; Yang X; Qin P; Wang P; Zhang H; Bai M; Wu R; Li F Oncogene; 2021 Apr; 40(17):3164-3179. PubMed ID: 33824474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]